4//SEC Filing
AVEO PHARMACEUTICALS INC 4
Accession 0001181431-13-052543
CIK 0001325879operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 8:54 AM ET
Size
5.0 KB
Accession
0001181431-13-052543
Insider Transaction Report
Form 4
Johnston David Brannon
Chief Financial Officer
Transactions
- Disposition to Issuer
Common Stock
2013-10-02−52,200→ 46,837 total
Footnotes (2)
- [F1]Shares underlying such disposition to the issuer were forfeited by the reporting person pursuant to the terms of two awards of restricted stock granted to the reporting person on January 31, 2012 and January 24, 2013 in connection with the determination of the issuer's Compensation Committee that certain specified strategic performance objectives were not met.
- [F2]Includes 3094 shares acquired on June 28, 2013 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeoperating
Related Parties
1- filerCIK 0001325879
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 8:54 AM ET
- Size
- 5.0 KB